Glooko, Author at Glooko

The diabetes industry won’t just evolve in 2026. It will continue to undergo a fundamental shift in how care is defined, delivered, and experienced. What was once a landscape dominated by manual tracking and reactive treatments has transformed into a proactive, connected, data-driven ecosystem of diabetes devices, management platforms, manufacturers, digital therapeutics, consumables, educators, and drug therapies.

In 2026, the focus is no longer just about managing diabetes, but about mastering it through integrated data, connected devices and apps, and AI-enabled insights. Glooko’s core mission has always been to bridge the gap between people living with diabetes and healthcare providers through clear, actionable data. This year, we are strengthening that connection by offering innovative solutions like EndoTool, developed by Monarch Medical Technologies, a Glooko Company, and Glooko. Together, these technologies can bridge the continuum of care from inpatient glycemic management to outpatient diabetes management.

To better understand where the industry is going, we asked our experts for their insights and predictions for 2026.

Advancing Diabetes and Glycemic Management in 2026

“The diabetes landscape is set for a massive transformation in 2026. With the launch of the CMS ACCESS Model, we are shifting from simply tracking data to rewarding positive health outcomes during hospital stays. However, as a wave of new CGMs, AI-enabled health software and wearables, and smart pens hits the market, these technologies can quickly overwhelm outpatient care teams. Trusted digital health solutions that bridge these settings, unifying disparate devices into one clear, actionable clinical picture using data, will be key.

This move toward data liquidity means vital information is no longer trapped in a single device or clinical encounter. By integrating inpatient systems with outpatient platforms, care can be more proactive and continuous, especially as new federal quality measures for glycemic safety take full effect this year. We aren’t just looking at numbers anymore; we need to use intelligent, AI-powered insights to make the daily burden of diabetes feel lighter. We’re moving beyond ‘tech for tech’s sake’ and toward a simpler, more connected reality that puts the person before the data.”

– Mike Alvarez, CEO, Glooko

The Rise of New Digital Health Standards and Connected Care

“In 2026, the strategic focus for health systems will shift from fragmented point solutions to a unified continuum of care. As hospitals face tightening margins and new outcome-based payment models like CMS ACCESS, they’ll seek integrated platforms that standardize management for chronic conditions like diabetes across both inpatient and outpatient settings. By consolidating disparate tools into a single, EHR-integrated ecosystem, systems can reduce the cost of maintaining multiple interfaces.

Remote patient monitoring will also see new life in 2026. New programs like the federal Rural Health Transformation Program are bridging the “digital divide” and refocusing on the benefits of connected, digital-forward care. This $50 billion funding allows underserved, rural clinics to adopt advanced AI and remote monitoring tools that were previously limited to urban centers, enabling evidence-based chronic condition management closer to home. By leveraging grants to modernize interoperability and cybersecurity, rural healthcare providers ensure that high-quality, connected diabetes care is no longer determined by a patient’s zip code, but is instead the universal standard.”

– Rich Glenn, President, Connected Care, Glooko

Evolving from Siloed Data Collection to Integrations and Precision Engagement

“This year, we will keep expanding our current support of episodic care to include continuous care, evolving beyond our expertise in data collection to the design of digital ecosystems that bridge the gap between people with diabetes, their device data, and healthcare providers. This shift will replace fragmented data silos with a unified infrastructure where information from diabetes devices and health monitoring apps flow seamlessly into clinicians’ primary workflows via EHR integrations. We must ensure that continuous data isn’t an overwhelming burden, but an enabling and actionable asset. This collaborative framework alleviates burnout by giving the entire care team an on-demand ‘single source of truth,’ allowing care teams to intervene proactively and spend less time navigating software and more time practicing at the tops of their licenses.

Given recent FDA guidance on wellness wearables and clinical decision support software, we may now be entering a new era of precision engagement fueled by AI. With the latest generations of CGM devices and automated insulin delivery (AID) systems, the field has already moved beyond just seeing data to predicting outcomes and using AI to forecast hypoglycemic events with immediate, context-rich alerts to the person with diabetes. This automation allows patients to manage their care more independently than ever before. However, people with diabetes still benefit from expert teams that can co-pilot their care. There will always be a vital need for care teams to step in when clinical complexity arises or the individual is not achieving their diabetes management goals.”

– Mark Clements, MD, PhD, Chief Medical and Strategy Officer, Glooko

Making Glycemic Safety a Mandatory Protocol

“In 2026, inpatient glycemic safety will transition from a clinical preference to a mandatory system requirement. With CMS now linking reimbursement and quality ratings to the reporting of severe glycemic events, hospitals can no longer rely on the manual vigilance of individual clinicians to manage insulin therapy. Success now requires moving away from fragmented “sliding scale” protocols and toward purpose-built platforms like EndoTool that ensure consistent, evidence-based dosing and the ability to track outcomes in real time. By treating glycemic management as core safety infrastructure, hospitals and health systems can reduce costly variability, meet new regulatory demands, and allow clinicians to focus on patient care rather than manual calculations.”

– Paul Chidester, MD, Medical Director, Glooko

View Dr. Chidester’s full 2026 outlook on glycemic safety

Solving Specialist Shortages and Clinician Burnout Through Integrated AI and Enhanced Patient Literacy

“Clinician burnout will remain a top priority in 2026, driven in part by the mental exhaustion of managing disjointed tools outside the EHR. This year marks a turning point: embedding integrated data and interoperability within existing workflows will automate administrative tasks, streamline documentation, and provide unified patient views for better clinical decisions. The result will likely be improved provider capacity, proactive care delivery, and sustainable models that optimize both clinical and operational outcomes.

As the endocrinologist shortage intensifies, primary care teams will increasingly leverage specialized healthcare AI tools, including ChatGPT for Healthcare, to reduce administrative burden and enable top-of-scope care delivery, effectively increasing capacity without adding staff.

We will continue to be immersed in the era of the AI-empowered patient. Patients already use tools like ChatGPT Health to synthesize their data, including glucose trends and lab results, before appointments. This increasing health literacy will continue to transform basic data reviews into high-value, collaborative discussions where both clinicians and patients leverage AI for more informed decision-making.”

– Trisha Martinez, BSN, MBA, RN, Senior Director, Clinical Transformation, Glooko

Securing the Digital Health Ecosystem to Thwart AI-Driven Cyberattacks

“In 2026, healthcare data privacy and cybersecurity will undergo a fundamental shift as cyber threats transition to AI-driven, autonomous models. Healthcare organizations must pivot toward ‘agentic resilience,’ a proactive approach leveraging agentic AI, autonomous systems capable of making decisions and executing tasks. These agents can address the vulnerabilities inherent in connected medical ecosystems, such as the possible cyberattack risks present in clinical workflows and medical devices, including connected insulin pumps and CGMs.

To mitigate security risks in 2026, healthcare organizations should also transition toward a robust security framework that replaces traditional passwords with identity-based access control and advanced authentication methods, such as biometric passkeys and MFA. By implementing universal verification, every access request can be rigorously validated regardless of its source, ensuring the integrity of clinical workflows and protecting sensitive health data from unauthorized entry.”

– Ben Chang, Vice President, Security and IT Operations, Glooko

Entering a Highly-Competitive, Integration-First Diabetes Device Ecosystem

“We’re entering the year in a global diabetes landscape that has matured into a competitive, integration-first ecosystem that demands collaboration. With the global diabetes device market projected to exceed $37.9 billion, we are seeing an influx of regional manufacturers offering new device alternatives, giving healthcare providers and people with diabetes a wider array of care choices. This diversification is further accelerated by the mainstream adoption of tubeless patch pumps, CGMs, and non-invasive wearable technologies tailored for the Type 2 diabetes and wellness segments.

From a partnership perspective, these trends reinforce a vital market truth that hardware is no longer a standalone solution. As the number of devices expands, the ultimate competitive advantage belongs to those who prioritize interoperability, integrating effortlessly into the patient’s life and the clinician’s EHR system.”

– Dave Conn, Executive Vice President, Global Alliances, Glooko

Furthering Connected Diabetes Care in Europe

“We’ll continue to move away from disconnected diabetes devices and toward integrated digital ecosystems. As connected care becomes the standard for delivering value, diabetes management will increasingly rely on a coordinated combination of medication, smart hardware, and artificial intelligence, all operating under the supervision of healthcare professionals through structured remote monitoring.

For remote monitoring to be effectively adopted, it must be embedded within national and regulatory frameworks defined by local health authorities. Strict alignment with evolving EU regulations on AI and health data will also remain a central priority.

In terms of devices, the evolution of algorithm-driven AID systems into sophisticated ‘digital companions’ will be the catalyst for a broader diabetes management transformation. By combining predictive AI with remote monitoring, healthcare providers can anticipate patient needs and manage populations remotely, offering a scalable solution to Europe’s workforce challenges by effectively shifting care from hospital settings into the home.”

– Alex Evans, Vice President, Connected Care, EMEA, Glooko

Smarter Technology to Empower People Living with Diabetes

“Over the past few years, managing my diabetes finally felt less like a full-time job and more like a background app running on my phone. We’ve moved away from the constant stress of finger sticks and manual math thanks to the latest AID systems and high-tech sensors that talk to each other better than ever before. These smart systems do the heavy lifting for many, catching highs and lows before they even happen, which takes a huge weight off the shoulders of people with diabetes. Even for those of us who don’t use a pump, connected smart pens can now automatically log every dose, so there’s a lot less guessing and worrying. In 2026, I think we’ll see even more technology that helps to further reduce burnout, keep costs more manageable, and help people stay in range, while thinking about diabetes a little less.”

– Hadley Horton, Senior Partner Manager, Glooko

Ready to prepare your hospital, health system, or clinic for the rest of 2026?

Contact our team for a demo of our outpatient Glooko diabetes management platform and inpatient EndoTool Glucose Management System.

In clinics and hospitals across Europe, healthcare providers are facing the common challenge of administrative overload.

We’ve heard that care teams at clinics and hospitals in the United Kingdom, Germany, Austria, Switzerland, Norway, Sweden, and Denmark need a more streamlined way to securely access our diabetes management platform and a more seamless integration of health data of patients into their daily clinical workflows.

Designed to streamline diabetes care workflows, our latest enhancements, including SSO and EHR integration, aim to provide secure access, automate workflows, and save care teams time.

Simplified and Secure Access with Single Sign-On

In fast-paced clinical environments, every second counts. Between patient consultations and appointment follow-ups, the last thing healthcare professionals need is another set of login credentials to memorize.

To increase efficiency, the Glooko diabetes management platform, compliant with GDPR and the NHS Data Security & Protection Toolkit, features single sign-on (SSO) functionality. Instead of using a separate username and password, clinical teams can access Glooko using their existing hospital credentials.

Why are clinics switching to SSO in Europe?

Seamless Access: The experience is intuitive. Users simply enter their professional email address and Glooko automatically authenticates them against their healthcare organization’s existing identity management platform.
Enhanced Security: By leveraging a hospital’s existing security protocols, SSO reduces the risks associated with weak or recycled passwords, keeping sensitive patient health data secure.
Maximum Efficiency: No more time wasted on login screens, forgotten password requests, and locked accounts.
Fast Implementation: The setup process is straightforward and we can typically have healthcare organizations connected to our platform, backed by leading security certifications, in less than two days.

End Manual Data Entry and Stop Toggling with EHR Interoperability

The administrative burden of maintaining patient records is one of the primary causes of clinician burnout. Too often, healthcare providers are forced to act as data entry clerks, manually transcribing glucose logs, insulin data, and reports into the EHR (electronic health record), instead of analyzing that data to improve care.

To eliminate this manual work and limit switching between screens, Glooko offers integrations designed to automate the flow of health information, making the EHR and our diabetes management platform work as a unified system.

By bridging the gap between systems, Glooko helps reduce manual burden and combat clinician burnout:

Launch from EHR: Open a patient’s full Glooko profile directly from the EHR interface. No extra tabs, no re-searching for names.
Sync to EHR: Automatically upload diabetes data and detailed reports from Glooko straight into the EHR to keep more comprehensive patient records.

By connecting these two systems, care teams can spend less time managing software and more time with their patients.

Ready to simplify your clinic’s digital environment?

Contact Team Glooko to find out the next steps needed to activate SSO and integrate our innovative diabetes management solution into the EHR.

For technical details, visit our API and EHR Integration Portal.

We’re excited to share the latest updates included in Glooko Web 25.4 and Glooko Mobile 6.14, which are designed to help healthcare providers and care teams move faster with easier-to-understand risk insights, while also making it easier for people living with diabetes to connect devices and apps and remotely share data with their care teams.

Enhancements to the Glooko Clinic Dashboard

The Glooko clinic dashboard, designed to improve diabetes population health management and available in select countries, now features enhanced usability and accuracy improvements, making risk insights clearer for faster action across clinics, hospitals, and health systems.

Other enhancements to our population health tool include:

Clearer risk visibility: An updated Time in Range layout makes low and very low glucose risk easier to identify at a glance.
Smarter patient ranking: Patients with diabetes are prioritized by risk category, then by severity of the triggering metric.
More precise metrics: Risk indicators are displayed with greater precision for clearer comparison and trend tracking.

More Efficient Patient Review in the Glooko Web App

The patient list in the Glooko Web App for healthcare providers has been enhanced to support faster, more efficient workflows and smoother navigation.

Care teams can now see more patient data at once with a wider default view that reduces horizontal scrolling, sort patients better with improved cues that make patient order easier to understand, and see key context through a revised header that stays visible as they scroll through the list.

Streamlined Clinical Workflows with Full Glooko Access in Epic

Healthcare providers using Patient Portal for Professionals can now access the full Glooko Web App directly within the Epic EHR system using SSO via SMaRT on FHIR, reducing platform switching and streamlining daily workflows.

Some of the benefits of this helpful enhancement include launching our diabetes management platform without leaving the EHR or logging in again, the use of core features including the clinic dashboard, patient list, and device assignment within Epic, faster review and action using key patient diabetes data, and reduced clinician burnout from not context switching.

If your clinic is interested in this feature, please email [email protected].

Simplified Device and App Management for People with Diabetes

Managing diabetes and health monitoring devices and apps is now quicker and intuitive in the Glooko Mobile App.

Our newly enhanced search and smarter filtering, better device categorization, and refreshed visuals, including logos, make it easier for people with diabetes to find and connect their devices and apps with fewer clicks. The update also features shortcuts to speed up Glooko’s seamless integration with more than 200 compatible diabetes and health monitoring devices and apps. Once connected, patient data can be securely shared remotely with care teams who can make more informed treatment decisions.

More Information on the Latest Glooko Release

To learn more about these updates, check out the full release notes on our Support Center or reach out to your dedicated Glooko Customer Success Manager.

Team Glooko will be at the American Diabetes Association’s 2026 Clinical Update Conference from February 6 to 8 in Houston, Texas, showcasing how our inpatient and outpatient solutions are helping hospitals and health systems address the growing challenge of glycemic safety and diabetes management and advancing team-based diabetes care.

Through our recent acquisition of Monarch Medical Technologies, we are now uniquely positioned to reduce glycemic risk, improve patient safety, and support overburdened clinical teams through coordinated expertise across the full continuum of care.

Here’s what you can learn about the Glooko diabetes management platform and EndoTool Glucose Management System, developed by Monarch Medical Technologies, a Glooko Company, at booth 17.

How to move from data overload to workflows that actually work: Disconnected systems, manual PDFs, and multiple logins slow care teams down and increase risk. Our EHR-integrated diabetes workflows in Glooko and EndoTool reduce manual burden, improve visibility, and enable consistent care across clinical, education, and operational teams.
Methods for preparing for mandatory CMS glycemic reporting: Hospitals are preparing for mandatory severe hypo- and hyperglycemia reporting from the Centers for Medicare & Medicaid Services. EndoTool, our patient-specific insulin dosing system, helps hospitals achieve unmatched clinical outcomes, reduce variability, and support CMS readiness with confidence.
Ways we align with the 2026 ADA Standards of Care: We’re helping clinicians and health systems turn the American Diabetes Association’s 2026 Standards of Care into reality. By streamlining data, enhancing team-based diabetes care, and delivering actionable insights, we’re bridging the gap between clinical guidelines and measurable outcomes to improve life for patients and their healthcare providers.
Tools for improving diabetes population health management: Designed for busy diabetes care team members, Glooko’s user-friendly clinic dashboard, now available in select countries, provides quick insights into patient trends and key clinic metrics to help clinics, hospitals, and health systems achieve better enterprise-wide diabetes management.

Leverage the power of team-based diabetes care

Schedule a demo with one of our experts at the ADA Clinical Update to see how your team can benefit from our innovative digital health platforms.

EndoTool is developed and marketed by Monarch Medical Technologies, a Glooko Company. EndoTool is an FDA-cleared Class II medical device indicated for inpatient use as described in its Instructions for Use. Glooko’s diabetes management platform and EndoTool are currently independent solutions. Patient-specific refers to EndoTool’s ability to use available patient information within the hospital’s electronic medical record to provide individualized insulin dosing recommendations. Recommendations are intended to assist, not replace, clinical judgment. All treatment decisions remain the responsibility of the licensed healthcare provider.

Through our ongoing commitment to enhancing diabetes care and simplifying diabetes management, we launched a redesigned food tracking experience in the Glooko Mobile App, making logging faster, more flexible, and even more insightful.

This powerful upgrade, featured in the Glooko Web App 25.3 and Mobile 6.13 release, is designed with the core purpose of making it easier for people with diabetes to log meals and for clinicians, endocrinologists, and the entire care team to streamline reviewing nutrition data alongside glucose trends, insulin doses, and exercise.

The new interface transforms the meal logging process, ensuring people with Type 1 diabetes, Type 2 diabetes, gestational diabetes, and prediabetes are more engaged with their nutrition tracking than ever before. For clinicians, the tool delivers the rich, contextual data needed for more impactful appointments and timely, data-backed interventions.

Ways for Easier and More Flexible Food Logging

The goal of the redesign was simple: make tracking food as quick and intuitive as possible for Glooko Mobile App users with diabetes. The new mobile experience allows users to:

Log Meals by Type: Start by simply selecting a meal type (breakfast, lunch, dinner, or snack).
Multiple Input Methods: Add food items instantly through a variety of convenient methods:
- Manual search of our expansive database of food items (Select languages only)
- Barcode scanning (U.S. only)
- Voice input (Select languages only)
- Quick add from our food database or through custom entry
Customize and Save Favorites: App users can now create custom food entries and easily mark meals or food items as favorites with a single tap of a heart for lightning-fast logging next time.
Review Before Saving: The ability to edit existing items for time, data, and serving size, or review the full meal with detailed nutritional summaries ensures accuracy before the data is saved.
View the Summary: A nutritional summary now appears after each logged meal to help users better understand their daily intake.

Providing Smarter Nutrition Insights and Visualizations

The new design goes beyond logging to provide users with a clearer picture of their diet composition:

Track Macro Distribution: The Glooko Mobile App now tracks the distribution of carbs, fat, and protein as a percentage of total calories per day. This vital feature helps users quickly assess if macro intake aligns with dietary goals and how it may be influencing glucose patterns.
Data-Packed Charts and Graphs: The simplified logging process means more consistent data, which is viewable in the Daily Log and a new Food Graph below the Carbs section of Charts and Graphs, allowing users to better understand diet-related glucose fluctuations and discuss potential changes with their care teams.
Enhanced Meal Visualization: Users and care teams can now view added meals directly in the History List of the Glooko web app, with each entry displaying the exact meal type, nutritional information, and details of the included food. This enhanced visualization provides a better understanding of how nutrition works together with insulin doses, exercise, medications, and weight. Previous views of carbs are still available in the Overview Graph, Daily Graph, Weekview, and Calendar.

A Comprehensive Approach to Diabetes Management

This revamped food tracking experience is more than just an update — it’s a powerful tool designed to foster better patient engagement and deliver insightful data people with diabetes and their healthcare providers need to manage diabetes more effectively.

With nutrition, exercise, medication, lifestyle management, and other health data, we’re creating a better way to manage diabetes. To get started, download the Glooko Mobile App on the App Store and the Google Play Store today.

*Not all product features are available in all countries.

We are thrilled to be an exhibitor at the ADCES Diabetes Technology Conference (DTC25) in Chicago on December 12 and 13. This unique event focuses on how cutting-edge technology, like Glooko, can empower diabetes care teams and improve outcomes for people with diabetes.

During the show, we’ll share at table #18 how Glooko delivers essential clinical advantages. Attendees will see firsthand how our diabetes management software, compatible with more than 200 diabetes and health monitoring devices and apps, enables care teams to effortlessly analyze patient data, streamline care coordination, and tailor interventions that can lead to improved health outcomes.

Here’s what we’ll showcase at DTC25:

New Glooko Clinic Dashboard: Designed specifically for busy healthcare providers, the new dashboard in Glooko offers an organized, at-a-glance view of patient trends and crucial clinic metrics. This powerful tool enables care teams to make more informed treatment decisions and build a stronger clinic strategy.
Seamless EHR Integrations: Glooko streamlines clinical workflows by integrating securely with leading EHR systems. This functionality eliminates the need for healthcare providers to switch platforms, giving care teams a complete, centralized view of all diabetes and related health data within a single, familiar interface, allowing them to work more efficiently.
EndoTool Glucose Management System, developed by Monarch Medical Technologies, a Glooko Company: Recently acquired by Glooko, EndoTool is the leading patient-specific inpatient insulin-dosing software trusted by 8 of the top 10 U.S. health systems to support safer, more consistent glycemic management at the bedside.

Elevate your practice with our innovative diabetes management platform

Ready to see how Glooko can elevate your clinic? Schedule a meeting with one of our experts at DTC25.

At Glooko, we believe that people living with diabetes are the ultimate experts in their own care. This driving principle is the heartbeat of our mission and is deeply woven into our company culture. Nowhere is this more evident than in our diabetes-focused employee resource group (ERG), the Glucose Gladiators. They ensure we live our mission daily by putting the voice of the user at the center of innovation, driving us to improve diabetes care.

Embedding Real-World Diabetes Perspectives into Glooko

Recognizing the critical need to embed real-world experience into our work, a group of employees living with diabetes came together to found the Glucose Gladiators, a vibrant internal community dedicated to connection and support. The ERG is remarkably diverse, including people with Type 1 and 2 diabetes, caregivers, former nurses and healthcare providers, and women who experienced gestational diabetes. Their firsthand perspectives are our greatest asset. By sharing their personal experiences, Glooko is better equipped as a company to create a diabetes management solution that truly resonates and fulfills our core mission.

The ERG’s purpose is to:

Educate other employees at Glooko about the realities of life with diabetes.
Foster cross-department collaboration that drives meaningful impact in diabetes care.
Help evolve our diabetes management platform to better serve the real-world needs of our users. By sharing their personal insights with our product team, we ensure our platform truly makes a difference.

Inside Look at the Glucose Gladiators’ Mission and Initiatives

Want to hear firsthand about the Glucose Gladiators’ impact? Meet Hadley Horton, a Senior Partner Manager at Glooko and a proud member of our ERG. Having lived with Type 1 diabetes since 2009, Hadley shares how the group’s personal experiences fuel their passion for improving the lives of others in the diabetes community.

MKT-0467

Healthcare providers struggle to manage large diabetes populations without a comprehensive view of patient data.

During this webinar, Glooko Chief Medical and Strategy Officer Mark Clements, MD, PhD, and Glooko Senior Clinical Transformation Director Trisha Martinez, BSN, MBA, RN, explore the new Glooko clinic dashboard, a powerful tool designed to streamline diabetes population health management and enable smarter care across hospitals, health systems, and clinics.

Our clinical experts take a deep dive into this user-friendly dashboard, available in select countries, and showcase its at-a-glance insights into patient trends and key clinic metrics that can help care teams easily interpret complex data for more efficient decision-making.

Ready to optimize diabetes population health management?

Contact Team Glooko for a demo of our new clinic dashboard, which helps healthcare teams manage large diabetes populations more effectively by prioritizing care and boosting patient engagement.

MKT-0468

During this Glooko 101 webinar, Glooko Senior Director of Clinical Transformation Trisha Martinez, BSN, MBA, RN, helps healthcare providers, including endocrinologists, nurses, and certified diabetes care and education specialists, get the most out of their professional Glooko account, reviewing core features and tools that support clinical workflows for both new users and those looking for a refresher.

This session also covers best practices for onboarding patients with diabetes using continuous glucose monitors (CGMs), including how to connect CGM data to Glooko to ensure seamless access to glucose trends and actionable insights from day one.

Time to Optimize your Diabetes Practice

Book a one-on-one session with Team Glooko today to better understand how to optimize Glooko from the start, get customized guidance on connecting CGM data, and gain access to actionable glucose trends care teams need.

MKT-0473

We’re thrilled to share that Glooko will be exhibiting at the 25th Annual Diabetes Technology Meeting (DTM), co-presented by the Diabetes Technology Society (DTS) and the American Diabetes Association, from October 28 to 30 in San Francisco, California.

At the diabetes industry event, we’ll showcase how our cutting-edge digital health platform is transforming care for people living with diabetes and their healthcare providers. Team Glooko is also looking forward to connecting with leading experts and innovators from around the globe as they explore the latest advancements shaping the future of diabetes technology.

Some of the exciting features and happenings that attendees will see at booth #15:

New Glooko Clinic Dashboard: The dashboard, designed for busy healthcare providers, offers a clear, organized view of patient trends and key clinic metrics based on TIDE metrics developed by Stanford. This new tool helps care teams interpret complex data at-a-glance, allowing them to make more efficient decisions for their patients with diabetes and develop a more effective clinic strategy.
EndoTool Glucose Management System, developed by Monarch Medical Technologies, a Glooko Company: EndoTool, recently acquired by Glooko, is the only patient-specific insulin dosing system designed to simplify glycemic management in hospitals. Its unique algorithm models each patient’s clinical characteristics and response to insulin, delivering optimal dosing recommendations to reduce the risk of severe hypoglycemia.
Industry-Leading Device Compatibility: Glooko seamlessly connects to an extensive ecosystem of more than 200 diabetes and health monitoring devices and apps, allowing people with diabetes to sync and share their health data with their care teams to enable better treatment decisions.
EHR Integrations: Glooko integrates with leading EHR systems to securely centralize diabetes data, eliminating the need for healthcare providers to switch platforms. This innovative functionality allows care teams to work more efficiently using a single interface with a complete view of their patients’ health data.

Expert Insights on the Power of Diabetes Health Data

Don’t miss the Actionable Data presentation given by Glooko Chief Medical and Strategy Officer Mark Clements, MD, PhD, at 1:30 p.m. PT on October 28. The presentation will offer deep insights into leveraging data to drive better outcomes in diabetes care.

Temple Health to Present New Data on Patient-Specific Subcutaneous Insulin Dosing

A highly anticipated poster,”Safety and Efficacy of a Patient-Specific Inpatient Dosing Application for Subcutaneous Insulin,” will present new evidence from Temple University Health System and Lewis Katz School of Medicine supporting the safety and efficacy of patient-specific insulin dosing for hospitalized patients on subcutaneous insulin. This study highlights outcomes from using the EndoTool SubQ application from Monarch Medical Technologies. The poster will be revealed at 4:30 p.m. PT on October 28.

Enhance Connected Care with Glooko

To find out more about our diabetes management platform from one of our experts at DTM 2025, schedule a meeting.